Clinical Decision Support System Market by Mode of Advice (Active CDSS, Passive CDSS), System (Knowledge-based CDSS, Nonknowledge-based CDSS), Delivery Mode, End User, Application - Global Forecast 2024-2030

Clinical Decision Support System Market by Mode of Advice (Active CDSS, Passive CDSS), System (Knowledge-based CDSS, Nonknowledge-based CDSS), Delivery Mode, End User, Application - Global Forecast 2024-2030


The Clinical Decision Support System Market size was estimated at USD 1.84 billion in 2023 and expected to reach USD 2.06 billion in 2024, at a CAGR 12.56% to reach USD 4.22 billion by 2030.A clinical decision support system (CDSS) works as an administrative and clinical tool that improves the operational efficiency of healthcare practices. The ongoing efforts in implementation of government regulations and initiatives increased the adoption of healthcare information technology (HCIT) solutions, significantly driving market growth. Moreover, the growing demand for intelligent software solutions to efficiently manage a rapidly increasing patient pool across the globe is boosting the growth of the global clinical decision support systems market. However, certain factors, such as the unwillingness of healthcare providers in installation and operation of clinical decision support systems, are challenging the market growth. In addition, higher costs of software installations and post-sale supports, along with a shortage of a trained and skilled workforce, are expected to limit market growth in forecast period. Nevertheless, the marketplace is anticipated to witness various innovations following R&D projects backed by significant corporate investments. Integrating cloud computing and interoperability platforms in different systems is expected to promote smooth functioning and seamless data flow further, thereby revving up the adoption of CDSS.Regional InsightsThe ongoing surge in demand for healthcare information technology solutions are responsible for market growth across North America, Europe, and the Asia-Pacific regions. The rapid technological advancements and the growing importance of providing quality healthcare services in the U.S. and Canada are making North America dominate the market, with a significant market share. Moreover, the launch of new technologies by the key vendors operating in the U.S. and Canada to integrate existing data handling systems such as electronic health records (EHR) and clinical decision systems offers predictive scenarios for patients, which is responsible for better patient experience and treatment. Moreover, Asia-Pacific is anticipated to be the fastest-growing region in the global CDSS market, attributed to increasing investments in the healthcare sector in Australia, China, India, and Japan. The governments in the APAC region are investing significantly in R&D, increasing the penetration of information technology in the medical field. Furthermore, enhanced collaboration between information technology companies and healthcare institutions is expected to boost the growth of global clinical decision support systems in the Asia-Pacific.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Clinical Decision Support System Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Clinical Decision Support System Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Clinical Decision Support System Market, highlighting leading vendors and their innovative profiles. These include Advanced Computer Software Group Limited, Cedar Gate Technologies, Cerner Corporation, CureMD.com, Inc., EBSCO Information Services, eClinicalWorks, LLC, Epic Systems Corporation, EvidenceCare, LLC, GE Healthcare, Hearst Corporation, Henisaja GmbH, Hera-MI, SAS, Koninklijke Philips N.V., Mocero Health Solutions Private Limited, Optum, Inc., Pinc AI by Premier Inc., Premier, Inc., Raapid.ai, Siemens Healthineers AG, Strata Decision Technology by Roper Industries, Inc., The International Business Machines Corporation, The Medical Algorithms Company Limited, VisualDX, and Wolters Kluwer N.V..

Market Segmentation & Coverage


This research report categorizes the Clinical Decision Support System Market to forecast the revenues and analyze trends in each of the following sub-markets:

Mode of Advice
Active CDSS
Passive CDSS
System
Knowledge-based CDSS
Nonknowledge-based CDSS
Delivery Mode
Cloud-Based
On-premise
End User
Clinics
Diagnostic Centers
Hospitals
Retail Pharmacy
Application
Care Plans
Diagnostic Decision Support
Disease Reference
Drug Databases
Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas
Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam
Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Clinical Decision Support System Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Clinical Decision Support System Market?
3. What are the technology trends and regulatory frameworks in the Clinical Decision Support System Market?
4. What is the market share of the leading vendors in the Clinical Decision Support System Market?
5. Which modes and strategic moves are suitable for entering the Clinical Decision Support System Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Clinical Decision Support System Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Need for improvement in the quality of care and reducing human errors in diagnostics and healthcare expenditure
5.1.1.2. Prominence of big data and mHealth solutions worldwide
5.1.1.3. Increasing adoption of cloud computing in healthcare sector
5.1.2. Restraints
5.1.2.1. Concerns associated with the privacy and security of data
5.1.3. Opportunities
5.1.3.1. Collaboration between research institutes and clinical decision support providers
5.1.3.2. Technological development in the healthcare solutions
5.1.4. Challenges
5.1.4.1. Complicated integration of CDSS within healthcare organizations
5.2. Market Segmentation Analysis
5.2.1. System: Significance of knowledge-based clinical decision systems
5.2.2. Delivery Mode: Importance of proper delivery mode for implementation of optimum clinical decision support systems
5.2.3. End User: Significance of clinical decision support systems across end user industries
5.2.4. Application: Emerging utilization of CDSS in wide scope of applications
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Clinical Decision Support System Market, by Mode of Advice
6.1. Introduction
6.2. Active CDSS
6.3. Passive CDSS
7. Clinical Decision Support System Market, by System
7.1. Introduction
7.2. Knowledge-based CDSS
7.3. Nonknowledge-based CDSS
8. Clinical Decision Support System Market, by Delivery Mode
8.1. Introduction
8.2. Cloud-Based
8.3. On-premise
9. Clinical Decision Support System Market, by End User
9.1. Introduction
9.2. Clinics
9.3. Diagnostic Centers
9.4. Hospitals
9.5. Retail Pharmacy
10. Clinical Decision Support System Market, by Application
10.1. Introduction
10.2. Care Plans
10.3. Diagnostic Decision Support
10.4. Disease Reference
10.5. Drug Databases
11. Americas Clinical Decision Support System Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Clinical Decision Support System Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Clinical Decision Support System Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
14.3.1. Agreement, Collaboration, & Partnership
14.3.1.1. AI Partnership to Reduce Hospital Nurses’ Documentation Burden
14.3.1.2. Medtronic and NVIDIA Collaborate to Build AI Platform for Medical Devices
14.3.2. New Product Launch & Enhancement
14.3.2.1. GE HealthCare Launches CardioVisio for Atrial Fibrillation, a Digital, Patient-Centric Clinical Decision Support Tool to Enable Precision Care
15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. Advanced Computer Software Group Limited
15.1.2. Cedar Gate Technologies
15.1.3. Cerner Corporation
15.1.4. CureMD.com, Inc.
15.1.5. EBSCO Information Services
15.1.6. eClinicalWorks, LLC
15.1.7. Epic Systems Corporation
15.1.8. EvidenceCare, LLC
15.1.9. GE Healthcare
15.1.10. Hearst Corporation
15.1.11. Henisaja GmbH
15.1.12. Hera-MI, SAS
15.1.13. Koninklijke Philips N.V.
15.1.14. Mocero Health Solutions Private Limited
15.1.15. Optum, Inc.
15.1.16. Pinc AI by Premier Inc.
15.1.17. Premier, Inc.
15.1.18. Raapid.ai
15.1.19. Siemens Healthineers AG
15.1.20. Strata Decision Technology by Roper Industries, Inc.
15.1.21. The International Business Machines Corporation
15.1.22. The Medical Algorithms Company Limited
15.1.23. VisualDX
15.1.24. Wolters Kluwer N.V.
15.2. Key Product Portfolio
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
FIGURE 1. CLINICAL DECISION SUPPORT SYSTEM MARKET RESEARCH PROCESS
FIGURE 2. CLINICAL DECISION SUPPORT SYSTEM MARKET SIZE, 2023 VS 2030
FIGURE 3. CLINICAL DECISION SUPPORT SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CLINICAL DECISION SUPPORT SYSTEM MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. CLINICAL DECISION SUPPORT SYSTEM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CLINICAL DECISION SUPPORT SYSTEM MARKET DYNAMICS
FIGURE 7. CLINICAL DECISION SUPPORT SYSTEM MARKET SIZE, BY MODE OF ADVICE, 2023 VS 2030 (%)
FIGURE 8. CLINICAL DECISION SUPPORT SYSTEM MARKET SIZE, BY MODE OF ADVICE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. CLINICAL DECISION SUPPORT SYSTEM MARKET SIZE, BY SYSTEM, 2023 VS 2030 (%)
FIGURE 10. CLINICAL DECISION SUPPORT SYSTEM MARKET SIZE, BY SYSTEM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. CLINICAL DECISION SUPPORT SYSTEM MARKET SIZE, BY DELIVERY MODE, 2023 VS 2030 (%)
FIGURE 12. CLINICAL DECISION SUPPORT SYSTEM MARKET SIZE, BY DELIVERY MODE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. CLINICAL DECISION SUPPORT SYSTEM MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 14. CLINICAL DECISION SUPPORT SYSTEM MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. CLINICAL DECISION SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 16. CLINICAL DECISION SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CLINICAL DECISION SUPPORT SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS CLINICAL DECISION SUPPORT SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CLINICAL DECISION SUPPORT SYSTEM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES CLINICAL DECISION SUPPORT SYSTEM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CLINICAL DECISION SUPPORT SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CLINICAL DECISION SUPPORT SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CLINICAL DECISION SUPPORT SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CLINICAL DECISION SUPPORT SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. CLINICAL DECISION SUPPORT SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 26. CLINICAL DECISION SUPPORT SYSTEM MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings